CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer

JUNKO MUKOHYAMA; KYOSUKE AGAWA; KIMIHIRO YAMASHITA; TAKERU MATSUDA; MASAHIRO SHINODA; OSAMU ITANO; YOSHIHIRO KAKEJI

doi:10.21873/anticanres.16561

Research ArticleExperimental Studies

CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer

JUNKO MUKOHYAMA, KYOSUKE AGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, MASAHIRO SHINODA, OSAMU ITANO and YOSHIHIRO KAKEJI

Anticancer Research August 2023, 43 (8) 3763-3767; DOI: https://doi.org/10.21873/anticanres.16561

JUNKO MUKOHYAMA

1Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, International University of Health and Welfare MITA Hospital, Tokyo, Japan;

2Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, International University of Health and Welfare Narita Hospital, Narita, Japan;

3Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: jmukohyama@iuhw.ac.jp

KYOSUKE AGAWA

3Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;

4Department of surgery, Japan Organization of Occupational Health and Safety Kobe Rosai Hospital, Kobe, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KIMIHIRO YAMASHITA

3Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKERU MATSUDA

3Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MASAHIRO SHINODA

1Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, International University of Health and Welfare MITA Hospital, Tokyo, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

OSAMU ITANO

2Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, International University of Health and Welfare Narita Hospital, Narita, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YOSHIHIRO KAKEJI

3Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 43, Issue 8

August 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 4 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer

JUNKO MUKOHYAMA, KYOSUKE AGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, MASAHIRO SHINODA, OSAMU ITANO, YOSHIHIRO KAKEJI

Anticancer Research Aug 2023, 43 (8) 3763-3767; DOI: 10.21873/anticanres.16561

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer

JUNKO MUKOHYAMA, KYOSUKE AGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, MASAHIRO SHINODA, OSAMU ITANO, YOSHIHIRO KAKEJI

Anticancer Research Aug 2023, 43 (8) 3763-3767; DOI: 10.21873/anticanres.16561

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells
Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer

Google Scholar

Keywords

CDX2
unresectable colon cancer
primary tumor resection

Main menu

User menu

Search

CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer

Purchase access

patientACCESS

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords